These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7658706)

  • 41. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
    Jin GH; Hirano T; Murakami M
    Int Immunol; 2008 Jun; 20(6):783-9. PubMed ID: 18448458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells.
    Sandau MM; Schluns KS; Lefrancois L; Jameson SC
    J Immunol; 2004 Dec; 173(11):6537-41. PubMed ID: 15557143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia.
    Papakosta D; Manika K; Gounari E; Kyriazis G; Kontakiotis T; Spyropoulos G; Kontakioti E; Zarogoulidis K
    Respirology; 2014 Jul; 19(5):748-54. PubMed ID: 24889556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activated lymphocytes and high liver expression of IFN-γ are associated with fulminant hepatic failure in patients.
    dos Santos DC; Neves PC; Azeredo EL; Pelajo-Machado M; Martinho JM; Pacheco-Moreira LF; Araújo CC; Cruz OG; de Oliveira JM; Pinto MA
    Liver Int; 2012 Jan; 32(1):147-57. PubMed ID: 22098464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
    von Lilienfeld-Toal M; Frank S; Leyendecker C; Feyler S; Jarmin S; Morgan R; Glasmacher A; Märten A; Schmidt-Wolf IG; Brossart P; Cook G
    Cancer Immunol Immunother; 2010 Jun; 59(6):829-39. PubMed ID: 20024547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apoptosis for prediction of radiotherapy late toxicity: lymphocyte subset sensitivity and potential effect of TP53 Arg72Pro polymorphism.
    Fuentes-Raspall MJ; Caragol I; Alonso C; Ramón y Cajal T; Fisas D; Seoane A; Carvajal N; Bonache S; Díez O; Gutiérrez-Enríquez S
    Apoptosis; 2015 Mar; 20(3):371-82. PubMed ID: 25398538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BOS Is Associated With Increased Cytotoxic Proinflammatory CD8 T, NKT-Like, and NK Cells in the Small Airways.
    Hodge G; Hodge S; Yeo A; Nguyen P; Hopkins E; Holmes-Liew CL; Reynolds PN; Holmes M
    Transplantation; 2017 Oct; 101(10):2469-2476. PubMed ID: 28926522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myelodysplastic syndromes: the role of the immune system in pathogenesis.
    Warlick ED; Miller JS
    Leuk Lymphoma; 2011 Nov; 52(11):2045-9. PubMed ID: 21663505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets.
    Nishikawa K; Saito S; Morii T; Kato Y; Narita N; Ichijo M; Ohashi Y; Takeshita T; Sugamura K
    Int Immunol; 1990; 2(6):481-6. PubMed ID: 1707657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
    Yoon JS; Newton SM; Wysocka M; Troxel AB; Hess SD; Richardson SK; Lin JH; Benoit BM; Kasprzycka M; Wasik MA; Rook AH
    J Invest Dermatol; 2008 Feb; 128(2):473-80. PubMed ID: 17713571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes of natural kill cell in peripheral blood of patients with myelodysplastic syndrome].
    Mi H; Fu R; Wang H; Qu W; Ruan E; Wang X; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Jiang H; Zhang W; Yue L; Shao Z
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):737-41. PubMed ID: 24844955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites.
    Page ST; Plymate SR; Bremner WJ; Matsumoto AM; Hess DL; Lin DW; Amory JK; Nelson PS; Wu JD
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E856-63. PubMed ID: 16352669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
    Gross CC; Schulte-Mecklenbeck A; Rünzi A; Kuhlmann T; Posevitz-Fejfár A; Schwab N; Schneider-Hohendorf T; Herich S; Held K; Konjević M; Hartwig M; Dornmair K; Hohlfeld R; Ziemssen T; Klotz L; Meuth SG; Wiendl H
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E2973-82. PubMed ID: 27162345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transformation of myelodysplastic syndrome into myeloid/natural killer cell precursor acute leukemia involving mainly lymph nodes.
    Kobayashi S; Sato K; Torikai H; Ogura K; Kobayashi A; Bamba Y; Ikeda T; Kimura F; Motoyoshi K
    Leuk Lymphoma; 2008 Feb; 49(2):342-5. PubMed ID: 18231923
    [No Abstract]   [Full Text] [Related]  

  • 57. Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients.
    Messaoudene M; Périer A; Fregni G; Neves E; Zitvogel L; Cremer I; Chanal J; Sastre-Garau X; Deschamps L; Marinho E; Larousserie F; Maubec E; Avril MF; Caignard A
    PLoS One; 2015; 10(7):e0133363. PubMed ID: 26218530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity.
    Giustiniani J; Marie-Cardine A; Bensussan A
    J Immunol; 2007 Feb; 178(3):1293-300. PubMed ID: 17237375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection.
    Cook KD; Kline HC; Whitmire JK
    J Leukoc Biol; 2015 Aug; 98(2):153-62. PubMed ID: 25986014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infiltrating CD8+ T lymphocytes, natural killer cells, and expression of IL-10 and TGF-beta1 in chemically induced neoplasms in male Wistar rats.
    Spinardi-Barbisan AL; Barbisan LF; de Camargo JL; Rodrigues MA
    Toxicol Pathol; 2004; 32(5):548-57. PubMed ID: 15603539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.